Lower serum brain-derived neurotrophic factor levels are associated with failure to achieve remission in patients with major depression after escitalopram treatment
Bun-Hee Lee,1 Young-Min Park,2 Tae Hyun Um,3 Sollip Kim3 1Department of Psychiatry, Gangnam Eulji Hospital, Eulji University, Seoul, 2Department of Psychiatry, 3Department of Laboratory Medicine, Ilsan Paik Hospital, Inje University College of Medicine, Goyang, South Korea Background: Remission,...
Enregistré dans:
Auteurs principaux: | Lee BH, Park YM, Um TH, Kim S |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2014
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/b5d55e3d91e948ada3e09aa3e30367cf |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Factors associated with failure to achieve remission and with relapse after remission in patients with major depressive disorder in the PERFORM study
par: Saragoussi D, et autres
Publié: (2017) -
Comparative efficacy of escitalopram in the treatment of major depressive disorder
par: Mazen K Ali, et autres
Publié: (2011) -
Brain-derived neurotrophic factor: role in depression and suicide
par: Yogesh Dwivedi
Publié: (2009) -
Escitalopram versus paroxetine controlled release in major depressive disorder: a randomized trial
par: Kishi T, et autres
Publié: (2017) -
Escitalopram vs duloxetine in acute treatment of major depressive disorder: meta-analysis and systematic review
par: Maneeton B, et autres
Publié: (2018)